183 related articles for article (PubMed ID: 21143164)
1. New anti-thrombotic drugs for stroke prevention.
Di Minno MN; Russolillo A; Camera M; Brambilla M; De Gregorio A; Tremoli E; Di Minno G
Curr Vasc Pharmacol; 2011 Nov; 9(6):723-32. PubMed ID: 21143164
[TBL] [Abstract][Full Text] [Related]
2. Filling the gap between science & clinical practice: prevention of stroke recurrence.
Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
[TBL] [Abstract][Full Text] [Related]
3. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry.
Stępińska J; Kremis E; Konopka A; Wożakowska-Kapłon B; Ruszkowski P; Kukla P; Kayani G
Kardiol Pol; 2016; 74(4):362-71. PubMed ID: 26365937
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
5. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses.
Kilickap M; Bosch J; Eikelboom JW; Hart RG
Can J Cardiol; 2016 Sep; 32(9):1108-16. PubMed ID: 27568871
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.
Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma C; Zint K; Elsaesser A; Bartels DB; Lip GY;
Am J Med; 2015 Dec; 128(12):1306-13.e1. PubMed ID: 26239094
[TBL] [Abstract][Full Text] [Related]
8. Prevention of cardioembolic stroke in patients with atrial fibrillation.
Weber R; Diener HC; Weimar C
Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1405-15. PubMed ID: 20936927
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves.
Eikelboom JW; Hart RG
Am J Hematol; 2012 May; 87 Suppl 1():S100-7. PubMed ID: 22389052
[TBL] [Abstract][Full Text] [Related]
10. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic treatment in the prevention of ischemic stroke.
Emre U; Rantanen K; Tatlisumak T
Curr Drug Targets; 2007 Jul; 8(7):817-23. PubMed ID: 17630934
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.
Dzeshka MS; Lip GY
Heart Fail Clin; 2016 Apr; 12(2):257-71. PubMed ID: 26968670
[TBL] [Abstract][Full Text] [Related]
13. [Limitations of anticoagulant therapy].
Martí-Fàbregas J; Delgado-Mederos R; Mateo J
Neurologia; 2012 Mar; 27 Suppl 1():27-32. PubMed ID: 22682207
[TBL] [Abstract][Full Text] [Related]
14. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
[TBL] [Abstract][Full Text] [Related]
15. [New aspects on "triple therapy" after coronary stent implantation].
Schlitt A
Dtsch Med Wochenschr; 2010 Oct; 135(41):2033-6. PubMed ID: 20925012
[TBL] [Abstract][Full Text] [Related]
16. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.
Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P;
BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802
[TBL] [Abstract][Full Text] [Related]
17. [Which antithrombotic treatment should be used in the treatment of an elderly patient with chronic atrial fibrillation?].
Mahé I; Grenard AS; Caulin C; Bergmann JF
Presse Med; 2003 Jul; 32(25):1170-4. PubMed ID: 13677880
[TBL] [Abstract][Full Text] [Related]
18. Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.
Le Heuzey JY; Bassand JP; Berneau JB; Cozzolino P; D'Angiolella L; Doucet B; Mantovani LG; Martelet M; Mouallem J; Muller JJ; Pieper K;
Arch Cardiovasc Dis; 2018 Dec; 111(12):749-757. PubMed ID: 29861295
[TBL] [Abstract][Full Text] [Related]
19. Stroke subtypes and interventional studies for transient ischemic attack.
Lavallée P; Amarenco P
Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
[TBL] [Abstract][Full Text] [Related]
20. Secondary prevention of stroke: a practical guide to drug treatment.
Koennecke HC
CNS Drugs; 2004; 18(4):221-41. PubMed ID: 15015903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
